This bill would impose stricter penalties on federal employees and witnesses who refuse to cooperate with congressional investigations. Under the legislation, anyone summoned to testify before Congress who refuses to answer relevant questions would face criminal charges including fines between $100 and $1,000 and jail time of one to twelve months, and would be permanently barred from federal employment. Additionally, federal employees convicted of perjury or making false statements during congressional testimony would be debarred from federal service and could be removed from their current positions. The bill also creates a fast-track process allowing members of Congress to introduce joint resolutions to rescind salaries and expenses for federal employees who violate these rules, with expedited voting timelines requiring committee action within 15 days and floor votes within 20 days. Any debarment or salary rescission would be subject to judicial review, allowing courts to overturn these actions if they find them improper.

The Ban Birth Tourism Act of 2026 would make foreigners who enter the United States primarily to give birth and obtain citizenship for their children inadmissible and deportable under immigration law. The bill targets people entering on tourist visas (B visas) who plan to have a baby within ten months of arrival, based on determinations made by the Department of Homeland Security, State Department, or consular officers. The legislation amends the Immigration and Nationality Act to classify birth tourism as grounds for denying entry and for removing aliens already in the country who engaged in this practice. The bill does not specify additional funding or implementation timelines. The measure would affect foreign nationals seeking to visit the United States while pregnant, as well as any aliens already in the country determined to have entered for this purpose.

The Biotechnology Diplomacy Leadership Act of 2026 creates a new position of Senior Biotechnology Official within the Department of State to coordinate U.S. diplomatic and policy efforts related to biotechnology on the global stage. The Secretary of State must appoint someone with significant expertise in biotechnology, international relations, and experience managing complex international biotechnology initiatives and national security issues within 90 days of the bill's enactment. The official will represent the State Department in international biotechnology discussions, coordinate with foreign governments and international organizations, oversee implementation of U.S. commitments to biotechnology initiatives, and report regularly to the Secretary of State on diplomatic progress. Key responsibilities include securing biotechnology supply chains, advancing research partnerships, facilitating data-sharing agreements, and supporting capacity-building programs in partner nations. The bill does not specify funding amounts or additional appropriations, focusing instead on establishing the position and defining its diplomatic and coordination responsibilities.

The Biotechnology Workforce Alignment Act of 2026 directs the National Science Foundation to develop programs that connect federal biotechnology research funding with workforce training and development. The NSF Director must identify high-demand biotechnology job areas such as biomanufacturing, synthetic biology, bioinformatics, and regulatory science, then create educational pathways with multiple entry and exit points to prepare workers for these careers. The bill requires the NSF to partner with universities, community colleges, minority-serving institutions, federal laboratories, and private companies to offer internships, apprenticeships, and other hands-on training opportunities aligned with industry needs. The Director must also track progress through metrics and submit reports to Congress every two years for eight years, assessing workforce gaps, program effectiveness, and America's competitive position in biotechnology compared to other countries. The legislation does not specify new funding amounts but directs the NSF to integrate these activities into its existing programs.

The Forestry Protection Act of 2026 would reduce tariffs and import fees on finished wood products by 50 percent if importers can prove the products are made entirely from raw wood material sourced from the United States. The bill affects companies importing wood products such as lumber, plywood, flooring, furniture, and paper pulp, as well as domestic wood producers who would benefit from lower-cost competition for U.S. materials. The legislation also requires the U.S. Customs and Border Protection Commissioner to issue detailed regulations within 90 days to verify that wood products qualify for the tariff reduction and to prevent fraud. Additionally, the bill imposes a 90-day advance notice requirement for any new or modified tariffs on wood products, during which the public would have at least 60 days to submit comments to the President. The bill aims to encourage the use of American timber in manufacturing while providing transparency and predictability for tariff decisions on wood products.

The Make DC Square Again Act would repeal an 1846 law that returned Alexandria County and the City of Alexandria to Virginia, restoring this territory to the District of Columbia. The bill's sponsors argue that the Constitution grants Congress the power to establish a federal district of up to ten miles square but does not authorize returning portions of that district to states, making the 1846 retrocession unconstitutional. If enacted, Arlington County and Alexandria would become part of DC and be subject to DC's laws rather than Virginia's, though existing property rights would be protected and any pending Virginia court cases could continue in Virginia courts. The change would take effect on the first day of the first fiscal year after the bill becomes law. The legislation has no dedicated funding since it primarily involves jurisdictional transfer rather than new federal spending.

H.Res. 1195 is a symbolic resolution that designates May as "National Myositis Awareness Month" to increase public understanding of myositis, a group of rare autoimmune diseases that cause chronic muscle inflammation and weakness. Myositis affects approximately one in ten Americans who have rare diseases and currently has no cure, often leading to delayed diagnosis and reduced quality of life for patients who experience debilitating symptoms like muscle pain, fatigue, and difficulty swallowing. The resolution acknowledges that more research is needed to understand the causes and treatments for the various types of myositis, and recognizes that patients frequently struggle to find healthcare providers with expertise in treating these conditions. The resolution does not provide any funding or establish new programs, but rather encourages all Americans to learn more about myositis and support those affected by it. This type of resolution has no direct fiscal impact and serves primarily to raise awareness and show congressional support for efforts to educate the public about the disease.

The CLEAR LABELS Act would require drug manufacturers to display detailed supply chain information on all prescription and over-the-counter drug labels and packaging. Specifically, drugs would need to show the name, location, and unique facility identifier of the original manufacturer of active pharmaceutical ingredients, the finished drug product manufacturer, and any distributors involved, either directly on the label or through accessible electronic portals like QR codes and barcodes. The bill applies to both finished drug products and active pharmaceutical ingredients used in drugs, and manufacturers must also provide paper copies of this information to anyone who requests them. Drug manufacturers would have at least one year from when the FDA issues final regulations to comply with the new labeling requirements, and the bill includes an exemption from existing customs country-of-origin marking rules for drugs that follow these new labeling standards.

Export Dispute Resolution ActThis bill revises the interagency dispute resolution process for export license applications. In particular, the bill requires the Operating Committee for Export Policy (an interagency body within the Department of Commerce's Bureau of Industry and Security) to resolve disputes related to specified matters by majority vote, including matters relating to countries that are subject to comprehensive U.S. arms embargoes.The bill also authorizes the committee chair to decide cases and matters that cannot be decided by majority vote.

The HBCU Empowerment and Reform Act, introduced in February 2026, modifies the federal definition of a historically Black college or university (HBCU) by changing the establishment date requirement from 1964 to November 8, 1965. This change would allow schools founded between 1964 and November 1965 to qualify as HBCUs if they meet all other eligibility criteria, potentially expanding federal funding and support to additional institutions. The bill affects HBCUs and schools that were established during this newly eligible period, as well as the students who attend them. The legislation amends the Higher Education Act of 1965 and was referred to the House Committee on Education and Workforce, though no specific funding amounts or implementation timeline are detailed in the available text.

H.R. 7649, introduced in February 2026, creates a mechanism to hold foreign individuals and entities financially accountable when they illegally divert or destroy U.S. humanitarian aid. The bill directs the Secretary of State to determine liability and seek recovery of the value of stolen or destroyed assistance, which can include aid delivered through international organizations. Any funds recovered become available for the State Department to use, or to transfer to other federal agencies if they originally funded the assistance. The Secretary of State has discretionary authority to waive liability if doing so is deemed in the national interest, giving the administration flexibility in handling sensitive diplomatic situations.

H.R. 6211 allows health care professionals to practice across state lines when they are working under a federal contract to respond to a declared emergency, without needing individual licenses in each state where they provide care. The bill applies when the President declares a disaster, the Secretary of Health and Human Services declares a public health emergency, or another federal agency certifies a national emergency requiring federal response. This affects doctors, nurses, and other licensed health care workers who may be deployed to assist in emergency response efforts. The legislation removes state-by-state licensing barriers to help the federal government mobilize medical personnel quickly during crises, though professionals must still work within their authorized scope of practice under their federal contract. The bill contains no new funding or specific timeline beyond immediate implementation once enacted.

The Litigation Reimbursement Act requires federal courts to automatically award attorneys' fees and litigation costs to defendants in criminal cases that go to trial but do not result in a conviction. Currently, courts have discretion to award such fees only when they determine the government's case was frivolous or brought in bad faith; this bill removes that discretion and makes fee awards mandatory in acquittals and cases with not-guilty verdicts. The legislation also expands fee-award requirements in civil cases by changing similar "may award" language to "shall award," making those awards mandatory as well. The bill applies to criminal cases pending on or after its enactment and is effective beginning in fiscal year 2026. The bill aims to shift litigation costs away from defendants when the government does not secure a conviction, potentially protecting individuals from substantial legal expenses even when they prevail in court.

The Incentivize Savings Act creates a financial incentive system for federal agencies to spend less than their annual budgets. When a federal agency has unexpended funds at the end of the fiscal year, the bill directs that 49 percent of those unspent dollars can be carried forward to the next year, 49 percent must go toward paying down the national debt, and 2 percent can be used for employee retention bonuses (capped at 10 percent of an employee's salary, with any remaining bonus funds also going to debt reduction). The legislation affects all executive branch agencies and departments. Additionally, any agency that triggers these savings rules cannot request a larger budget in the following year than it did in the current year, except for increases that match inflation as measured by the Consumer Price Index, creating a long-term budget constraint for agencies that successfully reduce spending.

The ROTOR Act directs the Defense Health Agency to study cancer rates among military rotary-wing helicopter pilots and aviation support personnel dating back to 1961. The study, conducted in two phases with the National Institutes of Health and National Cancer Institute, will first examine whether twelve specific cancer types (including brain, lung, breast, and pancreatic cancer) occur at higher rates among this group compared to the general population, with results due within one year. If the initial phase finds elevated cancer rates, a second phase will investigate potential causes—such as toxic fumes, fuels, electromagnetic radiation from radar systems, and other hazardous exposures from military service—with those findings due one year later. The bill affects current and former military aviators who receive Department of Defense health benefits and uses existing federal cancer databases to conduct the research, though no specific funding amounts are specified in the legislation.

The STATES Act would require states to reimburse the federal government for costs incurred when the National Guard is deployed to that state, but only under specific conditions. If the President determines within 30 days of a deployment's conclusion that a state government's negligence or wrongful action caused the need for federal Guard deployment, the President can direct the Department of Defense to calculate the total costs and reduce federal funding to that state by 100 percent of those costs. The bill does include a presidential waiver allowing the President to forgive reimbursement in cases of extreme state financial hardship or when deployments primarily protect federal property or enforce federal law. The legislation takes effect retroactively from June 1, 2025, and applies to all future National Guard deployments, making states potentially liable for federal expenses related to emergency responses deemed to result from state negligence.

H.Res. 277 is a symbolic resolution designating May 2025 as "National Myositis Awareness Month" to increase public understanding of myositis, a rare group of chronic autoimmune diseases that cause progressive muscle inflammation and weakness. Myositis affects roughly 1 in 10 Americans with rare diseases and includes several variants such as dermatomyositis, polymyositis, and inclusion body myositis, which can lead to serious complications like lung disease and shortened life expectancy. The resolution highlights that myositis is difficult to diagnose, leaving patients with delayed treatment and limited access to specialized healthcare providers, and notes that women and people of color experience disproportionate health disparities related to the condition. The measure calls on Congress to support awareness campaigns and encourages all Americans to become informed about myositis and support those affected by it. This resolution has no funding requirements or implementation timeline beyond designating the awareness month itself.

Economic Espionage Prevention ActThis bill authorizes the President to impose visa- and property-blocking sanctions on foreign adversary entities that knowingly engage in (1) economic and industrial espionage with respect to trade secrets and proprietary information owned by U.S. persons, (2) the provision of material support or services to a foreign adversaries' national security entities, or (3) the violation of U.S. export control laws. The bill cites regulations that define China, Russia, Iran, North Korea, Cuba, and the Maduro regime of Venezuela as foreign adversaries. The bill also limits certain exemptions from the President's authority under the International Emergency Economic Powers Act (IEEPA). IEEPA provides the President broad authority to regulate a variety of economic transactions following a declaration of national emergency, but exempts from this authority activities such as (1) the import or export of information or informational materials; (2) transactions ordinarily incident to international travel, such as the importation of personal baggage; and (3) personal communications, such as postal or telephonic communications, that do not transfer anything of value. Under the bill, the first two of these exemptions are not applicable if the President determines such imports and exports would seriously impair the ability to deal with a declared national emergency. Additionally, the bill specifies that the first and third exemptions listed above do not apply to bulk sensitive personal data or source code used in a connected software application.

H.R. 873 modifies how the Department of Defense reimburses healthcare providers under TRICARE, the health insurance program for military members, retirees, and their families. The bill requires the military to base payment rates on the specific location where care is provided—such as a hospital inpatient facility, hospital outpatient department, ambulatory surgery center, or doctor's office—rather than treating all providers the same regardless of location. When multiple reimbursement rates are available for the same service, the Secretary of Defense must pay the lowest authorized rate. The bill also requires claims to include unique location-specific provider identification codes to track where services were actually delivered. These changes take effect on January 1, 2026.

H.R. 874 modifies how the Department of Veterans Affairs pays healthcare providers under its Community Care Program, which serves veterans who receive care outside the VA system. The bill requires the VA to set different payment rates based on where care is delivered—such as hospital inpatient facilities, hospital outpatient departments (both on-campus and off-campus), ambulatory surgery centers, and physician offices—rather than using uniform rates regardless of location. The legislation also requires that payment claims include a unique geographic identifier to pinpoint the exact provider location, and mandates that when multiple payment rates could apply to the same service, the VA must pay the lowest rate. These changes take effect on January 1, 2026, and affect all veterans receiving community care services and the network of private healthcare providers that bill the VA for those services.

Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2025 or the PROTECTS Act of 2025This bill prohibits providing or using federal funds to perform, refer for, or reimburse any entity for certain gender transition procedures for an individual under the age of 18. The bill’s prohibition applies to certain gender transition procedures that are performed to intentionally change an individual’s body to no longer correspond to the individual's biological sex, including surgeries, medications, and implants specified in the bill. The bill provides exceptions for specified procedures, such as treating certain genetic abnormalities or preventing imminent death or impairment of a major bodily function, when performed by a health care provider with the consent of the individual’s parent or legal guardian.